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Abstract
Background: Information on cost-effectiveness of the range of HIV prevention interventions is a useful contributor
to decisions on the best use of resources to prevent HIV. We conducted this assessment for the state of Andhra
Pradesh that has the highest HIV burden in India.
Methods: Based on data from a representative sample of 128 public-funded HIV prevention programs of 14 types
in Andhra Pradesh, we have recently reported the number of HIV infections averted by each type of HIV
prevention intervention and their cost. Using estimates of the age of onset of HIV infection, we used standard
methods to calculate the cost per Disability Adjusted Life Year (DALY) saved as a measure of cost-effectiveness of
each type of HIV prevention intervention.
Results: The point estimates of the cost per DALY saved were less than US $50 for blood banks, men who have
sex with men programmes, voluntary counselling and testing centres, prevention of parent to child transmission
clinics, sexually transmitted infection clinics, and women sex worker programmes; between US $50 and 100 for
truckers and migrant labourer programmes; more than US $100 and up to US $410 for composite, street children,
condom promotion, prisoners and workplace programmes and mass media campaign for the general public. The
uncertainty range around these estimates was very wide for several interventions, with the ratio of the high to the
low estimates infinite for five interventions.
Conclusions: The point estimates for the cost per DALY saved from the averted HIV infections for all interventions
was much lower than the per capita gross domestic product in this Indian state. While these indicative cost-
effectiveness estimates can inform HIV control planning currently, the wide uncertainty range around estimates for
several interventions suggest the need for more firm data for estimating cost-effectiveness of HIV prevention
interventions in India.
Background
India has had substantial resources allocated for HIV/
AIDS control of which the major portion would be
spent on HIV prevention [1,2]. Efficient use of these
resources would take into account the gaps in coverage
of HIV prevention interventions, the cost of interven-
tions and their cost-effectiveness. The state of Andhra
Pradesh in south India, with a population of over 80
million, is estimated to have the highest burden of HIV
among all states in India [3]. We have recently reported
an economic analysis of the entire range of public-
funded HIV prevention interventions in Andhra Pra-
desh, taking into account their cost, the estimated HIV
infections that could be prevented by these interven-
tions, and the gaps in their coverage [4]. We now report
estimates of the cost-effectiveness of these HIV preven-
tion interventions and discuss the issues involved in
these estimations.
Methods
Sample and data collection
T h eA n d h r aP r a d e s hS t a t eA I D SC o n t r o lS o c i e t y
(APSACS) is the nodal agency that facilitates a variety
of public-funded HIV prevention interventions. Four of
these interventions are based in clinical settings: volun-
tary counselling and testing (VCT) centres, prevention
of parent to child transmission (PPTCT) centres, sexu-
ally transmitted infection (STI) clinics, and blood banks.
VCT and PPTCT are now offered at the same facility
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centre. Eight interventions are implemented by non-
governmental organisations targeting groups at high-risk
of HIV: women sex worker (SW) programmes, men
who have sex with men (MSM) programmes, truckers
programmes, composite programmes, workplace pro-
grammes, migrant labourer programmes, street children
programmes, and prisoner programmes. In addition,
APSACS implements a state-wide information, educa-
tion and communication (IEC) programme for the
general public (mass media campaigns), and previously
used to implement the state-wide condom promotion
programme. Of the total 551 programmes facilitated by
APSACS during the April 2005 to March 2006 fiscal
year, a representative sample of 128 programmes was
selected (Table 1) [4]. Data on the HIV prevention ser-
vices provided by these programmes, and the economic
cost of the programmes including personnel, recurrent
goods, recurrent services, capital goods and office space
rentals, were documented from written records and
interviews of programme staff by trained investigators
using procedures described previous that included qual-
ity control [4-10]. The adolescent education awareness
programme for HIV prevention that is facilitated by the
State Council of Education Research and Training was
not included in this assessment.
Cost-effectiveness calculations
We have previously reported the total HIV prevention
services provided through APSACS facilitated programs
and the economic cost of these services in Andhra
Pradesh in the 2005-2006 fiscal year, and based on the
estimated intervention effect per unit service we have
reported the number of HIV infections averted by each
intervention in this year along with the uncertainty
range calculated from sensitivity analysis with Monte
Carlo simulations using random values of input
variables (Table 2) [4]. This method and the detailed
calculations of HIV infections averted by each interven-
tion are shown in Additional file 1 as compared with
the situation if there was no intervention at all. From
this we calculated the cost per HIV infection averted
during the 2005-2006 fiscal year by each type of preven-
tion intervention for the services provided in Andhra
Pradesh during this year. We then calculated Disability
Adjusted Life Years (DALYs) saved as the sum of the
Years of Life Lost (YLL) and the Years Lost due to Dis-
ability (YLD) that would be saved for each HIV infection
averted by each prevention intervention using published
methods [11-14].
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Where a = age at death in years; L = standard expec-
tation of life in years at age a; r = discount rate; K =
age-weighting modulation factor; C = age-weighting
adjustment constant; b = constant from the age-weight-
ing function.
Table 1 Sampled programmes from among the public-funded HIV prevention interventions facilitated by APSACS in
Andhra Pradesh in the 2005-2006 fiscal year [4].
Interventions Total number of programmes Number of programmes sampled*
VCT centres 198 25
STI clinics 85 22
PPTCT clinics 101 16
Blood banks 56 14
Women SW programmes 20 16
MSM programmes 3 2
Trucker programmes 21 6
Composite programmes 23 6
Workplace programmes 4 3
Migrant labourer programmes 7 4
Street children programmes 6 3
Prisoner programmes 25 9
IEC for general public 1 1
Condom promotion programme 1 1
Total 551 128
*Sample of programmes selected for each intervention using stratification by the three regions of the state, and in some cases stratification also by sub-type of
intervention when applicable, to obtain representation proportional to the actual distribution.
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Where a = age at onset of disability in years; L =
duration of disability in years; D = disability weight;
r = discount rate; K = age-weighting modulation factor;
C = age-weighting adjustment constant; b =c o n s t a n t
from the age-weighting function.
We used the commonly used discount rate r = 0.03, i.
e. 3% yearly discount rate for the value of years of life
lost in the future. For calculation of DALYs with age-
weighting, previously suggested values for constants
were used: K = 1, C = 0.1658 and b = 0.04. As the use
of age-weighting in the calculation of DALYs is contro-
versial due to preferential weights given to young adults
as compared with children and elderly, we calculated
DALYs without age-weighting in which the value of the
age-weighting modulation factor K = 0 and C and b
become not applicable.
Based on estimated local trends, for sexually acquired
HIV in adults the average age at infection was assumed
as 30 years for men and 25 years for women. For sexu-
ally acquired HIV in street children, the average age at
infection was assumed as 17 years for both boys and
girls based on estimated local trends. The age at infec-
tion for mother to child transmission of HIV was con-
sidered as the first year of life. The average age at
infection from blood transfusion was estimated as
5 years in the 14 years and less age group, 30 years in
the 15-44 years age group, and 50 years in the 45 years
and above age group, based on local trends. DALYs
were calculated separately for men and women and a
weighted average calculated based on the proportion of
HIV infections averted in men and women by each
intervention.
The YLDs were calculated separately for pre-AIDS
and AIDS. The duration of HIV to pre-AIDS was con-
sidered as 6 years, from pre-AIDS to AIDS as 2 years,
and from AIDS to death as 1.5 years without anti-retro-
viral treatment [15]. As a very small fraction of persons
with HIV/AIDS were on antiretroviral treatment in
India at the time of this study, we calculated DALYs
saved without including prolonged life and additional
cost due to antiretroviral treatment. This would have to
be re-considered as the antiretroviral treatment becomes
more common.
DALYs saved for each HIV infection averted by each
intervention were computed with and without age-
weighting as YLLs + YLDs (Pre AIDS) + YLDs (AIDS).
Utilising the cost per HIV infection averted computa-
tions, we then calculated the cost per DALY saved for
Table 2 Services provided by public-funded HIV prevention interventions in Andhra Pradesh, their economic cost and
the estimated HIV cases averted in the 2005-2006 fiscal year [4].
Intervention Number of persons served* Total programme cost INR (US$)† Estimated number of HIV infections
averted‡
Point estimate Uncertainty range
VCT centres 261,421 38,552,074 (870,840) 1,310 327 - 2,800
PPTCT clinics 217,274 21,496,098 (485,568) 592 463 - 747
STI clinics 116,735 84,656,539 (1,912, 278) 2,315 1,705 - 3,064
Blood banks 107,912 7,570,027 (170,997) 1,755 1,431 - 2,082
Women SW programmes 40,732 57,915,975 (1,308,244) 1,330 629 - 2,164
MSM programmes 18,270 6,268,799 (141,604) 611 295 - 930
Trucker programmes 494,354 54,529,010 (1,231,737) 681 0 - 1,256
Composite programmes 147,194 39,122,674 (883,729) 250 65 - 417
Workplace programmes 19,855 7,713,881 (174,246) 22 7 - 35
Migrant labourer programmes 113,356 19,337,166 (436,801) 202 76 - 320
Street children programmes 46,892 8,802,798 (198,843) 38 0 - 130
Prisoner programmes 146,599 16,358,548 (369,518) 46 0 - 211
IEC for general public 33,000,000 234,846,584 (5,304,870) 498 0 - 4,290
Condom promotion programme 190,599 11,648,524 (263,125) 39 0 - 128
*As reported for the public-funded programmes in the 2005-2006 fiscal year; for blood banks the number is the blood units screened; IEC estimate based on
coverage of the 15-49 years old age group in Andhra Pradesh with HIV mass media campaigns through television, radio, print media and public events.
†INR is India Rupee; 1 US$ = INR 44.27 in the 2005-2006 fiscal year [15].
‡Point estimate calculated from HIV infections averted per unit service multiplied by the total number of persons served; uncertainty range calculated from the
5
th and 95
th percentile values for HIV infections averted per unit service obtained from 100,000 Monte Carlo simulations with @Risk software using random
values of input variables [4].
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verted to US$ using the average exchange rate of INR
44.27 for a US$ in the 2005-2006 fiscal year [16]. We
calculated the uncertainty range of these estimates
based on the 5
th and 95
th percentile values of HIV infec-
tions averted by each intervention computed previously
with sensitivity analysis through 100,000 iterations each
by Monte Carlo simulations using the @Risk software
(Palisade Corporation, Newfield, New York, USA).
Results
The lowest cost per HIV infection averted was that by
blood banks (INR 4,313, US $97) followed by MSM pro-
grammes (INR 10,265, US $232) and VCT clinics,
PPTCT clinics, STI clinics and women sex worker pro-
grammes (INR 29,425-43,554, US $665-984) (Table 3).
Truckers programmes cost INR 80,116 (US $1,810) and
migrant labourer programmes cost INR 95,943 (US
$2,167) per HIV infection averted, with the other pro-
grammes having a cost of INR 156,520-471,676 (US
$3,536-10,655) per HIV infection averted.
The DALYs saved per HIV infection averted were
somewhat lower without age-weighting than with age-
weighting the calculations for which are shown in the
Additional file 2, and therefore the cost per DALY saved
was somewhat higher without age-weighting (Tables 4
&5). Blood banks and MSM programmes had the lowest
cost per DALY saved, INR 176 (US $4) and INR 414
(US $9) respectively without age-weighting (Table 5).
T h ec o s tp e rD A L Ys a v e dw i t h o u ta g ew e i g h t i n gf o r
VCT clinics, PPTCT clinics, STI clinics and women sex
worker programmes was INR 1,119-1,662 (US $25-38).
This was followed by INR 6,043-8,316 (US $137-188)
per DALY saved for composite and street children pro-
grammes, and INR 11,532-18,141 (US $260-410) for
composite, prisoners, workplace and IEC programmes
(Table 5).
The ratio of the highest to the lowest value in the cost-
effectiveness uncertainty range was less than 2 for blood
banks, PPTCT and STI clinics, 3-5 for MSM, women
SW, migrant labourer and workplace programmes, 6-9
for composite programmes and VCT clinics, and infinite
for truckers, street children, prisoners, IEC and condom
promotion programmes based on sensitivity analysis
using the plausible range of input variables (Table 5).
Discussion
Cost-effectiveness estimates for HIV prevention inter-
ventions are scarce in India. This is a useful component
of the evidence base needed for efficient use of available
resources to prevent HIV [17]. When resources are
scarce, cost-effectiveness estimates help make choices
where to put the money for maximum health benefit.
However, decisions on resource allocation also take into
account many factors other than cost-effectiveness. Our
estimates of the cost-effectiveness of the range of
public-funded HIV prevention interventions in Andhra
Pradesh state reported in this paper are the most
comprehensive information available on this topic so far
from India.
The World Bank a decade ago as part of its project
appraisal for the second national HIV/AIDS control pro-
gramme of India estimated the cost per DALY saved as
US$2.7 for sex worker programmes, US$2.4 for STI
Table 3 Cost per HIV infection averted for public-funded HIV prevention interventions in Andhra Pradesh state of
India.
Intervention Cost per HIV infection averted* INR (US$)
Point estimate Uncertainty range
VCT centres 29,425 (665) 13,769 - 117,977 (311 - 2,665)
PPTCT clinics 36,329 (821) 28,760 - 46,449 (650 - 1,049)
STI clinics 36,568 (826) 27, 627 - 49, 637 (624 - 1,121)
Blood banks 4,313 (97) 3,637 - 5,290 (82 - 120)
Women SW programmes 43,554 (984) 26,767 - 92,031 (605 - 2,079)
MSM programmes 10,265 (232) 6,744 - 21,246 (152 - 480)
Trucker programmes 80,116 (1,810) 43,427 - infinite (981 - infinite)
Composite programmes 156,520 (3,536) 93,919 - 604,068 (2,121 - 13,645)
Workplace programmes 357,057 (8,065) 223,282 - 1,110,031 (5,044 - 25,074)
Migrant labourer programmes 95,943 (2,167) 60,492 - 254,609 (1,366 - 5,751)
Street children programmes 229,524 (5,185) 67,771 - infinite (1,531 - infinite)
Prisoner programmes 353,576 (7,987) 77,491 - infinite (1,750 - infinite)
IEC for general public 471,676 (10,655) 54,743 - infinite (1,237 - infinite)
Condom promotion programme 299,823 (6,773) 91,217 - infinite (2,060 - infinite)
*Calculated from programme cost and number of HIV infections averted in Table 2; figures presented to the nearest INR and nearest US$.
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previous report based on data from a sex worker pro-
gramme during 1999-2003 in Gujarat, the cost per
DALY saved was reported as US$5.5 with an uncertainty
range of US$3-12 [19]. There are substantial differences
between these estimates and ours reported in this paper.
The cost per DALY saved estimates for sex worker
programmes by the World Bank and the Gujarat study,
and for STI management by the World Bank, are an
order of magnitude lower than our estimates of US$38
(uncertainty range US$23-79) for sex worker pro-
grammes and US$31 (uncertainty range US$24-43) for
STI clinics. The cost per DALY saved estimate for VCT
by the World Bank is 2.5 times lower than our estimate
Table 4 Cost per DALY saved with age-weighting for public-funded HIV prevention interventions in Andhra Pradesh
state of India.
Intervention DALYs saved per HIV infection averted*
(with age-weighting)
Cost per DALY saved† (with age-weighting) INR (US$)
Point estimate Uncertainty range
VCT centres 28.1 1,047 (24) 490 - 4,198 (11 - 95)
PPTCT clinics 38.4 946 (21) 749 - 1,210 (17 - 27)
STI clinics 28.0 1,306 (30) 987 - 1,773 (22 - 40)
Blood banks 25.4 170 (4) 143 - 208 (3 - 5)
Women SW programmes 27.8 1,567 (35) 963 - 3,310 (22 - 75)
MSM programmes 25.3 406 (9) 267 - 840 (6 - 19)
Trucker programmes 27.4 2,924 (66) 1,585 - infinite (36 - infinite)
Composite programmes 27.3 5,733 (130) 3,440 - 22,127 (78 - 500)
Workplace programmes 27.4 13,031 (294) 8,149 - 40,512 (184 - 915)
Migrant labourer programmes 27.4 3,502 (79) 2,208 - 9,292 (50 - 210)
Street children programmes 33.1 6,934 (157) 2,047 - infinite (46 - infinite)
Prisoner programmes 27.4 12,904 (291) 2,828 - infinite (64 - infinite)
IEC for general public 27.4 17,214 (389) 1,998 - infinite (45 - infinite)
Condom promotion programme 27.4 10,942 (247) 3,329 - infinite (75 - infinite)
*Calculations for DALYs saved per HIV infection averted by each intervention shown in the Additional file.
†Calculated from cost per HIV infection averted in Table 3 and DALYs saved per HIV infection; figures presented to the nearest INR and nearest US$.
Table 5 Cost per DALY saved without age-weighting for public-funded HIV prevention interventions in Andhra
Pradesh state of India.
Intervention DALYs saved per HIV
infection averted*
(without age-weighting)
Cost per DALY saved†
(without age-weighting) INR (US$)
Ratio of high to low
estimates in uncertainty range
Point estimate Uncertainty range
VCT centres 26.3 1,119 (25) 524 - 4,486 (12 - 101) 8.6
PPTCT clinics 29.9 1,215 (27) 962 - 1,553 (22 - 35) 1.6
STI clinics 26.3 1,390 (31) 1,050 - 1,887 (24 - 43) 1.8
Blood banks 24.5 176 (4) 148 - 216 (3 - 5) 1.5
Women SW programmes 26.2 1,662 (38) 1,022 - 3,513 (23 - 79) 3.4
MSM programmes 24.8 414 (9) 272 - 857 (6 - 19) 3.2
Trucker programmes 26.0 3,081 (70) 1,670 - infinite (38 - infinite) infinite
Composite programmes 25.9 6,043 (137) 3,626 - 23,323 (82 - 527) 6.4
Workplace programmes 26.0 13,733 (310) 8,588 - 42,693 (194 - 964) 5
Migrant labourer programmes 25.9 3,704 (84) 2,336 - 9,830 (53 - 222) 4.2
Street children programmes 27.6 8,316 (188) 2,455 - infinite (55 - infinite) infinite
Prisoner programmes 26.0 13,599 (307) 2,980 - infinite (67 - infinite) infinite
IEC for general public 26.0 18,141 (410) 2,105 - infinite (48 - infinite) infinite
Condom promotion programme 26.0 11,532 (260) 3,508 - infinite (79 - infinite) infinite
*Calculations for DALYs saved per HIV infection averted by each intervention shown in the Additional file.
†Calculated from cost per HIV infection averted in Table 3 and DALYs saved per HIV infection; figures presented to the nearest INR and nearest US$.
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lower point estimates for the cost per DALY saved are
likely due to different assumptions used in the HIV
t r a n s m i s s i o nm o d e l s .W eh a v ep r e v i o u s l yr e p o r t e dt h e
basis of the validity of our transmission model on which
our cost-effectiveness assumptions are based [4]. The
large differences between our cost-effectiveness esti-
mates and those reported previously for sex worker pro-
grammes, STI management and VCT merit further
probing with actual longitudinal data to estimate the
impact of these interventions in preventing HIV.
The World Bank project appraisal for the second
national HIV/AIDS control programme also estimated a
cost of US$128 per DALY saved for mother to child
transmission intervention with ziduvidine (AZT) [18].
Our estimate of US$27 (uncertainty range US$22-35)
per DALY saved for PPTCT clinics with nevirapine is
about five times lower than the previous World Bank
estimate a major reason for which is the much lower
cost of nevirapine now than that of AZT at the time of
World Bank estimates a decade ago. Another economic
analysis has estimated a cost of $586 per HIV infection
averted for nationwide screening of pregnant women
and treatment with nevirapine in India and $275 per
HIV infection averted if this programme were imple-
ment only in high HIV prevalence states including
Andhra Pradesh [20]. Our estimate of US$821 (uncer-
tainty range US$650-1049) per HIV infection averted by
PPTCT clinics is about three times higher than the pre-
vious estimate for high prevalence states. While this
may be partly due to the previous higher HIV preva-
lence estimates in the general population and pregnant
w o m e ni nI n d i a ,w h i c hh a v ed r o p p e dd o w nb ya b o u t
half due to the availability of recent population-based
data [21,22], this may be due to other methodological
differences too. This again underscores the need for
actual longitudinal data to estimate the HIV infections
averted and cost-effectiveness.
As compared with the per capita gross domestic pro-
duct (GDP) of Andhra Pradesh state (INR 28,063, US
$634) [23], the point estimates of the cost per DALY
saved for six HIV prevention interventions in Andhra
Pradesh were less than 10% of the per capita GDP, all
except one intervention were less than half the per
capita GDP, and for one intervention was 65% of the
per capita GDP, indicating that these interventions were
generally quite cost-effective. Interventions costing less
than per capita GDP are considered highly cost-effective
[24]. However, a striking finding of our analysis is the
very wide uncertainty range of the cost-effectiveness
estimates for several HIV prevention interventions. The
infinite ratio of the highest to the lowest values in the
uncertainty range for truckers, street children, prisoners,
IEC and condom promotion programmes, and a ratio of
9 for VCT, suggest that more concrete data are required
for input variables that go into the estimation of HIV
infection averted by these interventions which in turn
directly affect the cost-effectiveness estimates. We there-
fore suggest that the cost-effectiveness estimates
reported by us that have a very wide uncertainty ranges
should be considered only indicative at this stage. On
the other hand, the upper end of uncertainty range of
the cost per DALY saved was less than half the per
capita GDP for blood banks, PPTCT clinics, STI clinics,
VCT centres, MSM programmes, women sex worker
programmes and migrant labourer programmes, sug-
gesting that even at the high end of uncertainty range of
the current estimates these HIV prevention interven-
tions have good cost-effectiveness.
There are some limitations of our analysis. Both the
cost of interventions and the calculation of HIV infec-
tions averted that we computed for cost-effectiveness
estimates are for a single year. While the intervention
effect may also have a beneficial impact on preventing
HIV in subsequent years, we do not have adequate data
on which to base justifiable assumptions and calcula-
tions for this. Not including this aspect would tend to
underestimate the cost-effectiveness of interventions in
our calculations. However, as we present similar cross-
sectional annual calculations for each intervention, our
approach is consistent across interventions. Neither the
future treatment cost of HIV/AIDS and associated dis-
eases averted by prevention of HIV infection, nor the
D A L Y st h a tw o u l db es a v e di ft h a tt r e a t m e n tc o s tw e r e
incurred, are included in our cross-sectional calcula-
tions. Increasingly common availability of anti-retroviral
treatment in India could influence the cost-effectiveness
calculations if the cost of treatment per additional
DALY saved were substantially higher or lower than the
cost per DALY saved due to HIV prevention interven-
tions. We are unable to comment which way this would
go, but for now our cross-sectional single year calcula-
tions are consistent for all interventions.
The trends of cost-effectiveness of the various public-
funded HIV prevention interventions in our analysis
from Andhra Pradesh state may be applicable to the
other high HIV burden states in southern India, but it
would be difficult to generalise these trends to the other
states which have a lower level of HIV burden and less
developed HIV prevention services at this stage. In addi-
tion to the public-funded HIV prevention interventions
analysed in this paper, it would be useful to understand
the cost-effectiveness of HIV prevention interventions
funded from other sources. In this regard, the cost-effec-
tiveness assessment being undertaken as part of the eva-
l u a t i o no ft h eG a t e sF o u n d a t i o nf u n d e dA v a h a nA I D S
India Initiative is likely to provide useful complementary
data [25].
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mates would evolve as the HIV interventions are scaled
u p .W eh a v ep r e v i o u s l yr e p o r t e dt h a tt h eu n i tc o s to f
services for sex workers doubled over three years in
Andhra Pradesh due to increase in the intensity of ser-
vices suggestive of better quality services, and the unit
cost of VCT reduced to half over this period due to
higher client volume without an indication of decrease
in quality of services [9]. The increase in scale of ser-
vices at some stage may also result in less efficiency as
more effort has to be spent in order to get to the resis-
tant hard to reach sub-groups. Therefore several fac-
tors come into play that influence the cost-
effectiveness in opposite directions at various stages of
the development of HIV prevention interventions.
Understanding the evolution of cost-effectiveness
would benefit from actual longitudinal data on HIV
infections averted by the prevention interventions in
India.
Conclusions
The cost-effectiveness estimates of the range of public-
funded HIV prevention interventions reported in this
paper are a useful addition to the evidence base needed
for an efficient use of resources to control HIV in India.
The point estimates for the cost per DALY saved due to
the averted HIV infections was much lower than the per
capita gross domestic product for all interventions.
Major differences between these estimates of cost-effec-
tiveness and some reported by others earlier underscore
the need for standardized and explicit methodology for
such estimates. The very wide uncertainty range for sev-
eral of our cost-effectiveness estimates highlights the
need for more robust actual longitudinal data in India
for more firm estimates.
Additional file 1: Calculation of the effect of interventions on
reducing HIV. This file shows calculation of HIV infections averted by
each HIV prevention intervention in Andhra Pradesh state of India.
Additional file 2: Calculation of Disability Adjusted Life Years
(DALYs) saved. This file shows calculation of Disability Adjusted Life
Years (DALYs) saved for each HIV infection averted by HIV prevention
interventions in Andhra Pradesh state of India.
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